Make Better Decisions

  • Identify first generic entrants
  • Obtain formulation and manufacturing information
  • Drug patents in 130+ countries

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Johnson and Johnson
Harvard Business School
US Department of Justice

Generated: February 25, 2018

DrugPatentWatch Database Preview

Drugs in MeSH Category Sympatholytics

« Back to Dashboard

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Covis Pharma BvBETAPACEsotalol hydrochlorideTABLET;ORAL019865-001Oct 30, 1992AB1RXYesNo➤ Sign Up➤ Sign Up➤ Sign Up
AllerganBETAGANlevobunolol hydrochlorideSOLUTION/DROPS;OPHTHALMIC019219-002Dec 19, 1985ATRXYesYes➤ Sign Up➤ Sign Up➤ Sign Up
Tris Pharma IncCLONIDINEclonidineTABLET, EXTENDED RELEASE;ORAL022500-002Dec 3, 2009DISCNNoNo➤ Sign Up➤ Sign Up➤ Sign Up
Covis Pharma BvBETAPACEsotalol hydrochlorideTABLET;ORAL019865-002Oct 30, 1992AB1RXYesYes➤ Sign Up➤ Sign Up➤ Sign Up
Aurobindo PharmaATENOLOLatenololTABLET;ORAL078512-002Oct 31, 2007ABRXNoNo➤ Sign Up➤ Sign Up➤ Sign Up
ApotheconATENOLOLatenololTABLET;ORAL073317-001Mar 20, 1992DISCNNoNo➤ Sign Up➤ Sign Up➤ Sign Up
Sandoz IncCARTEOLOL HYDROCHLORIDEcarteolol hydrochlorideSOLUTION/DROPS;OPHTHALMIC075476-001Jan 3, 2000ATRXNoYes➤ Sign Up➤ Sign Up➤ Sign Up
MylanATENOLOLatenololTABLET;ORAL074126-002Mar 23, 1994DISCNNoNo➤ Sign Up➤ Sign Up➤ Sign Up
Lupin LtdNADOLOLnadololTABLET;ORAL209309-002Oct 5, 2017ABRXNoNo➤ Sign Up➤ Sign Up➤ Sign Up
SandozNADOLOLnadololTABLET;ORAL074501-002Nov 9, 1995ABRXNoNo➤ Sign Up➤ Sign Up➤ Sign Up
This preview shows a limited number of results
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Express Scripts
Boehringer Ingelheim
Cantor Fitzgerald

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2018 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch: